Liv Veldeman

8PUBLICATIONS
80CO-AUTHORS
Radiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 13, 2026
Circadian genotypes in PER3 and time of prostate cancer radiotherapy interact to affect risk of late side-effects.

|Mar 09, 2026
Chromosomal damage in breast cancer patients undergoing different radiotherapy schemes.

Renu Dayal, Lama Ramadan, Liv Veldeman

|Feb 23, 2026
Demographic and clinical profiles of patients with primary and second primary cancers: identifying biomarkers of sensitivity to radiotherapy-induced cancer.

Magdalena Płódowska, Lama Ramadan, Renu Dayal

|Oct 13, 2025
Integration of Dose Surface Maps and Genetic Data Identifies the Lower Posterior Rectum as a Key Region for Toxicity after Prostate Cancer Radiotherapy.

Artemis Bouzaki, Eliana Vasquez Osorio, Sarah Kerns

|Mar 03, 2025
A Polygenic Risk Score for Late Bladder Toxicity Following Radiotherapy for Non-Metastatic Prostate Cancer.

Manzur Farazi, Xin Yang, Carson J Gehl

|Jan 06, 2025
Association of radiation-induced normal tissue toxicity with a high genetic risk for rheumatoid arthritis.

Alan McWilliam, Deborah Marshall, Sarah L Kerns

Pageof 2

Frequent Collaborators

4 joint publications

Elena Sperk

4 joint publications

Ana Vega

4 joint publications

Tiziana Rancati

4 joint publications

Adam Webb